Nebenwirkungen · Abasaglar (previously Abasria)
ABASAGLAR 100 units/mL solution for injection in a cartridge · Abschnitt 4.8 · PDF-Seite 9
HOS-130198 · Präparat HOS-096865
In general, the safety profile for children and adolescents (≤ 18 years of age) is similar to the safety profile for adults. The adverse reaction reports received from post marketing surveillance included relatively more frequent injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) in children and adolescents (≤ 18 years of age) than in adults. Clinical study safety data are not available for children under 2 years.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-13T13:04:00Z · SHA-256 8a48895fa1a195b1b88589b8cd0ee2e2b7b31cd9b013ed1703865e2f5891fd58 · Passage 7174ece6b32894b0feaf530807c12067a23f8049a4034288793f5559786bb3f6 · Zeichen 4184–4659 im Abschnitt